Abstract

Objective. Retrospective analysis of the treatment of complications after endoscopic retrograde transpapillary interventions. Material and methods. There were 5701 endoscopic retrograde interventions for the period from 01.01.2008 to 01.01.2019. Overall incidence of complications was 1.5%, mortality rate – 0.24%. Bleeding after endoscopic papillosphincterotomy developed in 13 (0.22%) cases, acute postoperative pancreatitis in 49 (10.85%) cases, ERCPassociated perforation in 24 (0.42%) patients. Results. Endoscopic approach (epinephrine injection into the edges of major duodenal papilla and cautery) was usually effective for bleeding after endoscopic retrograde cholangiopancreatography. Massive intraoperative bleeding required surgical treatment in one case with favorable outcome. There were no cases of recurrent bleeding. One patient died due to severe bleeding in 3 days after surgery. ERСP-associated (“retroduodenal”) perforation occurred in 24 (0.42%) patients. Endoscopic treatment was undertaken in 16 cases and was effective in 15 (93.75%) cases. Overall mortality among patients with ERCP-induced perforation was 20.8%. An attempt of pancreatic duct stenting for postoperative pancreatitis was made in 30 cases; successful procedure was in 28 (93.3%) cases. Surgery resulted recovery in 26 (86.7%) patients. Progression of acute postoperative pancreatitis followed by death occurred in 2 cases despite successful pancreatic duct stenting. Mortality rate was 25%. Conclusion. Treatment of ERCP-associated complication is lengthy, time-consuming and expensive. Timely diagnosis and assessment of severity of complications is essential. It is necessary to determine an adequate surgical approach. Everyone should keep in mind all possible risk factors, clearly define the indications for ERCP and follow the technique of the procedure strictly in order to reduce complication rate. In our opinion, endoscopic approach is advisable for post-ERCP complications, because conventional surgery results higher postoperative mortality, increased duration and cost of treatment.

Highlights

  • An attempt of pancreatic duct stenting for postoperative pancreatitis was made in 30 cases; successful procedure was in 28 (93.3%) cases

  • Progression of acute postoperative pancreatitis followed by death occurred in 2 cases despite successful pancreatic duct stenting

  • Preetha M., Chung Y.F., Chan W.H., Ong H.S., Chow P.K., Wong W.K., Ooi L.L., Soo K.C. Surgical management of endoscopic retrograde cholangiopancreatography-related perforations

Read more

Summary

Objective

Retrospective analysis of the treatment of complications after endoscopic retrograde transpapillary interventions. Bleeding after endoscopic papillosphincterotomy developed in 13 (0.22%) cases, acute postoperative pancreatitis in 49 (10.85%) cases, ERCPassociated perforation in 24 (0.42%) patients. Overall mortality among patients with ERCP-induced perforation was 20.8%. Progression of acute postoperative pancreatitis followed by death occurred in 2 cases despite successful pancreatic duct stenting. Treatment of ERCP-associated complication is lengthy, time-consuming and expensive. Endoscopic approach is advisable for post-ERCP complications, because conventional surgery results higher postoperative mortality, increased duration and cost of treatment. Эндоскопические ретроградные транспапиллярные вмешательства широко применяются в повседневной практике в диагностике и лечении различных заболеваний органов гепатопанкреатодуоденальной зоны (ГПДЗ) и при ряде из них являются стандартом. Как и любому другому инвазивному вмешательству, ЭПСТ неизбежно сопутствуют определенные специфические осложнения, в ряде наблюдений приводящие к летальному исходу. Именно это заставило нас тщательно изучить и проанализировать причины развития наиболее частых и серьезных осложнений ретроградных транспапиллярных вмешательств в нашей клинике, а также оценить результаты различных видов их коррекции

Материал и методы
Эндоскопическое вмешательство
Результаты и обсуждение
Фактор риска
Метод лечения
Факторы риска
Участие авторов
Findings
Список литературы

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.